2026 Global: Bioanalytical Testing Services Market-Competitive Review (2032) report
Description
The 2026 Global: Bioanalytical Testing Services Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for bioanalytical testing services market by geography and historical trend. The scope of the report extends to sizing of the bioanalytical testing services market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Eurofins Scientific, Charles River Laboratories, SGS Société Générale de Surveillance SA, Labcorp, WuXi AppTec, Thermo Fisher Scientific Inc., Intertek Group plc, ICON plc, Pace Analytical Services, LLC, and Precision Medicine Group, LLC stand as the ten major companies dominating the Bioanalytical Testing Services Market. These firms lead through extensive global networks, advanced technologies like LC-MS/MS and immunochemistry platforms, and comprehensive services spanning pharmacokinetics (PK), toxicokinetics (TK), biomarker analysis, and stability studies for small molecules and biologics. Their dominance stems from regulatory expertise in GLP/GMP compliance, strategic expansions, and partnerships that accelerate drug development from preclinical to clinical stages, addressing rising demands in biopharma and personalized medicine.
Eurofins Scientific excels with over 800 laboratories worldwide, offering bioanalytical testing, contract research, and GMP-compliant stability studies for pharmaceuticals. Charles River Laboratories provides end-to-end services including bioanalytical mass spectrometry for PK assessments and safety evaluations, bolstered by its preclinical expertise. SGS delivers raw material testing, regulatory compliance support, and global bioanalysis through partnerships like its 2023 collaboration with Agilex Biolabs. Labcorp integrates pharmacokinetic, toxicology, and clinical trial testing, with a 2025 expansion in cell and gene therapy labs enhancing its capacity. WuXi AppTec supports GLP TK/PK analysis and regulatory submissions across therapeutic modalities.
Thermo Fisher Scientific (via PPD) powers clinical trials with lab services, impurity testing, and mass spectrometry, leveraging AI-driven automation. Intertek Group offers pharmaceutical analysis and bioanalysis for drug development, ensuring quality assurance across 100+ countries. ICON plc specializes in bioanalytical labs, biomarker analysis, and method validation for clinical development. Pace Labs provides stability, dissolution, and microbiology testing for small molecules and biologics. Precision Medicine Group delivers comprehensive PK/PD services, recently highlighted in market expansions alongside BioAgilytix's partnerships. These leaders innovate amid a market growing at 16.11% CAGR to meet complex biopharma needs.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for bioanalytical testing services market by geography and historical trend. The scope of the report extends to sizing of the bioanalytical testing services market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Eurofins Scientific, Charles River Laboratories, SGS Société Générale de Surveillance SA, Labcorp, WuXi AppTec, Thermo Fisher Scientific Inc., Intertek Group plc, ICON plc, Pace Analytical Services, LLC, and Precision Medicine Group, LLC stand as the ten major companies dominating the Bioanalytical Testing Services Market. These firms lead through extensive global networks, advanced technologies like LC-MS/MS and immunochemistry platforms, and comprehensive services spanning pharmacokinetics (PK), toxicokinetics (TK), biomarker analysis, and stability studies for small molecules and biologics. Their dominance stems from regulatory expertise in GLP/GMP compliance, strategic expansions, and partnerships that accelerate drug development from preclinical to clinical stages, addressing rising demands in biopharma and personalized medicine.
Eurofins Scientific excels with over 800 laboratories worldwide, offering bioanalytical testing, contract research, and GMP-compliant stability studies for pharmaceuticals. Charles River Laboratories provides end-to-end services including bioanalytical mass spectrometry for PK assessments and safety evaluations, bolstered by its preclinical expertise. SGS delivers raw material testing, regulatory compliance support, and global bioanalysis through partnerships like its 2023 collaboration with Agilex Biolabs. Labcorp integrates pharmacokinetic, toxicology, and clinical trial testing, with a 2025 expansion in cell and gene therapy labs enhancing its capacity. WuXi AppTec supports GLP TK/PK analysis and regulatory submissions across therapeutic modalities.
Thermo Fisher Scientific (via PPD) powers clinical trials with lab services, impurity testing, and mass spectrometry, leveraging AI-driven automation. Intertek Group offers pharmaceutical analysis and bioanalysis for drug development, ensuring quality assurance across 100+ countries. ICON plc specializes in bioanalytical labs, biomarker analysis, and method validation for clinical development. Pace Labs provides stability, dissolution, and microbiology testing for small molecules and biologics. Precision Medicine Group delivers comprehensive PK/PD services, recently highlighted in market expansions alongside BioAgilytix's partnerships. These leaders innovate amid a market growing at 16.11% CAGR to meet complex biopharma needs.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
